Author:
Keene D.L.,Whiting S.,Humphreys P.
Abstract
ABSTRACT:We report the results of a double-blind cross-over study comparing clobazam and placebo in the treatment of refractory childhood epilepsy. Fifty-two percent of patients had greater than 50% reduction in their seizure frequency when taking the clobazam. During the placebo phase no patient recorded a greater than 50% reduction in seizure frequency. Sex, age, seizure type, intellect did not appear to differentiate clobazam responsive from nonresponsive patients. Only 2/21 patients had behavioral changes on the drug sufficiently severe to require the patient to drop out of the study prematurely. Drug interactions between clobazam and the other anticonvulsant medicines did not occur.
Publisher
Cambridge University Press (CUP)
Subject
Clinical Neurology,Neurology,General Medicine
Reference5 articles.
1. Antiepileptic Properties of Clobazam, a 1–5 Benzodiazepine, in Man
2. Add-on trial of clobazam in 36 intractable epileptic patients, with plasma level correlations;Guberman;Can J Neurol Sci,1989
3. Benzodiazepines in the Treatment of Children with Epilepsy
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献